When taken together, both JUN and AGTR1 might be significant targets against the etiological spectrum of metabolic hepatic disease.
← all excerpts
A roadmap to unveil the mechanism(s) of natural indole-derived molecules against NAFLD-derived HCC via systems pharmacology.
1
—
—